Cargando…
Serum Adropin Level in the Early Period of ST-Elevation Myocardial Infarction and Its Relationship With Cobalamin and Folic Acid
Background: Studies on biomarkers in the diagnosis of myocardial infarction are ongoing. Adropin is a biomarker that has been studied and has been shown to have different effects. This study aimed to examine the adropin level of patients with myocardial infarction within the first 24 hours, as well...
Autores principales: | Adıyaman, Mehmet Şahin, Canpolat Erkan, Revşa Evin, Kaya, İlyas, Aba Adıyaman, Özlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851843/ https://www.ncbi.nlm.nih.gov/pubmed/36686140 http://dx.doi.org/10.7759/cureus.32748 |
Ejemplares similares
-
LX-8000R and UriSed 2 fully automated urine analyzers comparison to manual microscopic examination
por: Evin, Canpolat Erkan Revşa, et al.
Publicado: (2022) -
Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era
por: Kaya, Ali̇ N, et al.
Publicado: (2023) -
The Relationship Between Coronary Collateral Circulation and Serum Adropin Levels
por: Vural, Asli, et al.
Publicado: (2023) -
Naltrexone-Associated Non-ST-Elevated Myocardial Infarction
por: Gubitosa, James C, et al.
Publicado: (2020) -
Examining the Timeliness of ST-elevation Myocardial Infarction Transfers
por: Ward, Michael J., et al.
Publicado: (2021)